UBS Group’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$64.9M Buy
869,789
+453,692
+109% +$33.8M 0.01% 1025
2025
Q1
$26.4M Buy
416,097
+223,585
+116% +$14.2M ﹤0.01% 1607
2024
Q4
$15M Buy
192,512
+168,466
+701% +$13.2M ﹤0.01% 2007
2024
Q3
$1.93M Buy
24,046
+5,240
+28% +$421K ﹤0.01% 3055
2024
Q2
$1.56M Sell
18,806
-39,308
-68% -$3.25M ﹤0.01% 3052
2024
Q1
$4.96M Sell
58,114
-13,973
-19% -$1.19M ﹤0.01% 2200
2023
Q4
$6.16M Buy
72,087
+27,618
+62% +$2.36M ﹤0.01% 1821
2023
Q3
$3.98M Sell
44,469
-25,399
-36% -$2.28M ﹤0.01% 2023
2023
Q2
$5.95M Buy
69,868
+11,056
+19% +$941K ﹤0.01% 1763
2023
Q1
$4.87M Buy
58,812
+15,563
+36% +$1.29M ﹤0.01% 1873
2022
Q4
$3.4M Buy
43,249
+37,274
+624% +$2.93M ﹤0.01% 2124
2022
Q3
$442K Buy
5,975
+919
+18% +$68K ﹤0.01% 3473
2022
Q2
$329K Sell
5,056
-14,800
-75% -$963K ﹤0.01% 3631
2022
Q1
$1.26M Sell
19,856
-13,583
-41% -$859K ﹤0.01% 3030
2021
Q4
$1.77M Buy
33,439
+30,020
+878% +$1.59M ﹤0.01% 2960
2021
Q3
$241K Sell
3,419
-275
-7% -$19.4K ﹤0.01% 4152
2021
Q2
$246K Sell
3,694
-14,433
-80% -$961K ﹤0.01% 4198
2021
Q1
$2.01M Sell
18,127
-5,276
-23% -$586K ﹤0.01% 2769
2020
Q4
$2.78M Sell
23,403
-13,209
-36% -$1.57M ﹤0.01% 2350
2020
Q3
$3.19M Buy
36,612
+30,890
+540% +$2.69M ﹤0.01% 2054
2020
Q2
$512K Sell
5,722
-5,792
-50% -$518K ﹤0.01% 3371
2020
Q1
$1.15M Sell
11,514
-104,784
-90% -$10.4M ﹤0.01% 2566
2019
Q4
$13.4M Buy
116,298
+60,904
+110% +$7M ﹤0.01% 1301
2019
Q3
$6.99M Buy
55,394
+26,586
+92% +$3.35M ﹤0.01% 1616
2019
Q2
$3.47M Sell
28,808
-10,210
-26% -$1.23M ﹤0.01% 2081
2019
Q1
$3.41M Sell
39,018
-20,231
-34% -$1.77M ﹤0.01% 2034
2018
Q4
$5.93M Sell
59,249
-2,484
-4% -$249K ﹤0.01% 1576
2018
Q3
$7.07M Buy
61,733
+26,961
+78% +$3.09M ﹤0.01% 1638
2018
Q2
$3.12M Buy
34,772
+20,376
+142% +$1.83M ﹤0.01% 2214
2018
Q1
$1.05M Buy
14,396
+2,185
+18% +$160K ﹤0.01% 2989
2017
Q4
$709K Sell
12,211
-4,085
-25% -$237K ﹤0.01% 3228
2017
Q3
$731K Buy
16,296
+4,814
+42% +$216K ﹤0.01% 3209
2017
Q2
$453K Sell
11,482
-1,230
-10% -$48.5K ﹤0.01% 3404
2017
Q1
$516K Sell
12,712
-6,340
-33% -$257K ﹤0.01% 3252
2016
Q4
$766K Buy
19,052
+7,246
+61% +$291K ﹤0.01% 3015
2016
Q3
$427K Sell
11,806
-1,829
-13% -$66.2K ﹤0.01% 3245
2016
Q2
$396K Buy
13,635
+3,534
+35% +$103K ﹤0.01% 3309
2016
Q1
$353K Buy
10,101
+3,287
+48% +$115K ﹤0.01% 3372
2015
Q4
$220K Sell
6,814
-3,401
-33% -$110K ﹤0.01% 3704
2015
Q3
$330K Buy
10,215
+1,895
+23% +$61.2K ﹤0.01% 3373
2015
Q2
$344K Buy
8,320
+2,992
+56% +$124K ﹤0.01% 3498
2015
Q1
$239K Buy
5,328
+1,811
+51% +$81.2K ﹤0.01% 3680
2014
Q4
$132K Buy
+3,517
New +$132K ﹤0.01% 4041